JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ROBSON, R. D.
Right arrow Articles by LAFORCE, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ROBSON, R. D.
Right arrow Articles by LAFORCE, S.
Journal of Pharmacology And Experimental Therapeutics, Vol. 169, Issue 1, 120-131, 1969
Copyright © 1969 by American Society for Pharmacology and Experimental Therapeutics


AN INVESTIGATION INTO THE BRADYCARDIC EFFECTS OF ST 155 [2-(2,6-DICHLOROPHENYLAMINO)-2-IMIDAZOLINE HCI] IN THE ANESTHETIZED DOG

R. D. ROBSON 1, H. R. KAPLAN 1, and SUSANNE LAFORCE 1

1 Warner-Lambert Research Institute, Morris Plains, New Jersey

When barbiturate-anesthetized dogs were given pronethalol or guanethidine, ST 155 [2-(2,6-dichiorophenylamino)-2-imidazoline HCI] caused bradycardia and induced bradycardic responses to epinephrine and norepinephrine. The catecholamines and ST 155 initially did not affect heart rate of pronethalol-pretreated dogs, but, with repeated small doses of ST 155, gradually increasing bradycardias were obtained without comparable changes in the pressor effects of these agents. Despite complications introduced by changes in sympathetic tone, the influence of repeated doses of ST 155 was also recognizable in dogs without pronethalol pretreatment. Pronethalol, interruption of pressure-sensitive reflex pathways or the reduction of pressor responses by alpha adrenergic blockade separately modified the size and duration of the bradycardia and in combination abolished the bradycardia of ST 155. In morphine-chloralose-anesthetized dogs, in which heart rate appeared to be largely under vagal control, ST 155 caused bradycardia which was not affected by sympathetic blockade but was abolished by atropine or bilateral vagotomy. These results indicate that, in addition to the reported central suppression of sympathetic outflow, ST 155 can cause bradycardia by enhancing pressuresensitive, compensatory reflexes.

Submitted on January 6, 1969
Accepted on May 13, 1969




This article has been cited by other articles:


Home page
CirculationHome page
C. C. Lang, G. H. Rayos, D. B. Chomsky, A. J. J. Wood, and J. R. Wilson
Effect of Sympathoinhibition on Exercise Performance in Patients With Heart Failure
Circulation, July 1, 1997; 96(1): 238 - 245.
[Abstract] [Full Text]


Home page
ANGIOLOGYHome page
J. C. Hutchison, W. H. Wilkinson, and A. B. Lintgen
The Use of Clonidine Hydrochloride in Ambulatory Hypertensive Patients
Angiology, November 1, 1971; 22(11): 647 - 658.
[PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics.